SIMCERE PHARMACEUTICAL GROUP Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
SIMCERE PHARMACEUTICAL GROUP had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of CNY 2.07 billion as of 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2013-04-26
- 2012-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.07B CNY.
- 2011-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.19B CNY.
- 2010-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.05B CNY.
- 2009-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.21B CNY.
CNY
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2012-12-31 | 2.07B CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 2.19B CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 2.05B CNY 20-F · filed 2013-04-26 |
| 2009-12-31 | 2.21B CNY 20-F · filed 2013-04-26 |
| 2008-12-31 | 2.30B CNY 20-F · filed 2012-04-25 |
USD
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2012-12-31 | $332.64M 20-F · filed 2013-04-26 |